Lista de obras - Philip Clarke - Dominio Público Uruguay

A Patient-Level Model to Estimate Lifetime Health Outcomes of Patients With Type 1 Diabetes

artículo científico publicado en 2020

A meta-analysis of health state valuations for people with diabetes: explaining the variation across methods and implications for economic evaluation ⬇️

artículo científico publicado el 7 de abril de 2011

A meta-analysis of the relative risk of mortality for type 1 diabetes patients compared to the general population: exploring temporal changes in relative mortality.

artículo científico publicado en 2014

A model to estimate the lifetime health outcomes of patients with type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS) Outcomes Model (UKPDS no. 68).

artículo científico publicado en 2004

A note on the decomposition of the health concentration index.

artículo científico publicado en 2003

A randomized trial of fellowships for early career researchers finds a high reliability in funding decisions

artículo científico

A randomized, placebo-controlled trial of pentoxifylline on erythropoiesis-stimulating agent hyporesponsiveness in anemic patients with CKD: the Handling Erythropoietin Resistance With Oxpentifylline (HERO) trial

artículo científico publicado en 2014

A randomized-controlled trial of high- or low-volume intravenous Plasma-Lyte(®) to prevent hypotension during sedation for colonoscopy

artículo científico publicado en 2016

Adapting and validating diabetes simulation models across settings: Accounting for mortality differences using administrative data ⬇️

artículo científico publicado el 13 de junio de 2013

Alexander Sutherland: A Forgotten Pioneer of Health Economics in Australia?

article

Allogeneic blood transfusion reduces murine pulmonary natural killer (NK) activity and enhances lung metastasis of a syngeneic tumour

article

An economic evaluation of atenolol vs. captopril in patients with Type 2 diabetes (UKPDS 54).

artículo científico publicado en 2001

Aspects of Multicomponent Integrated Care Promote Sustained Improvement in Surrogate Clinical Outcomes: A Systematic Review and Meta-analysis

artículo científico publicado en 2018

Assessing the impact of visual acuity on quality of life in individuals with type 2 diabetes using the short form-36.

artículo científico publicado en 2006

Calculating the concentration index when income is grouped

artículo científico publicado en 2009

Can Self-Rated Health Scores Be Used for Risk Prediction in Patients With Type 2 Diabetes?

article

Challenges and opportunities for the Pharmaceutical Benefits Scheme

scientific article published on 01 February 2012

Change in bias in self-reported body mass index in Australia between 1995 and 2008 and the evaluation of correction equations

artículo científico publicado en 2011

Changes in Inequalities of Access to Dental Care in Australia 1977-2005

article

Changes in Quality of Life Associated with Complications of Diabetes: Results from the ADVANCE Study

artículo científico publicado en 2015

Citizens from 13 countries share similar preferences for COVID-19 vaccine allocation priorities

scientific article published in 2021

Comparability of patient-reported health status: multicountry analysis of EQ-5D responses in patients with type 2 diabetes

artículo científico publicado en 2011

Cost effectiveness of self monitoring of blood glucose in patients with non-insulin treated type 2 diabetes: economic evaluation of data from the DiGEM trial.

artículo científico publicado en 2008

Cost of Antihyperglycemic Medications in the United States—Reply

artículo científico publicado en 2016

Cost-benefit analysis and mammographic screening: a travel cost approach

artículo científico publicado en 1998

Cost-effectiveness analysis of intensive blood-glucose control with metformin in overweight patients with type II diabetes (UKPDS No. 51).

artículo científico publicado en 2001

Cost-effectiveness of artemisinin combination therapy for uncomplicated malaria in children: data from Papua New Guinea

artículo científico publicado en 2011

Cost-effectiveness of screening for anal cancer using regular digital ano-rectal examinations in men who have sex with men living with HIV

artículo científico publicado en 2016

Cost-utility analyses of intensive blood glucose and tight blood pressure control in type 2 diabetes (UKPDS 72).

artículo científico publicado en 2005

Cutting random funding decisions ⬇️

artículo científico publicado el 20 de enero de 2011

Development of life-expectancy tables for people with type 2 diabetes

artículo científico publicado en 2008

Do Model-Based Studies in Chronic Obstructive Pulmonary Disease Measure Correct Values of Utility? A Meta-Analysis.

artículo científico publicado en 2016

Does income-related health inequality change as the population ages? Evidence from Swedish panel data

artículo científico publicado en 2010

End-stage renal disease risk equations for Hong Kong Chinese patients with type 2 diabetes: Hong Kong Diabetes Registry

artículo científico publicado en 2006

Estimating Health-State Utility for Economic Models in Clinical Studies: An ISPOR Good Research Practices Task Force Report.

artículo científico publicado en 2016

Estimating The Potential Impact Of Insurance Expansion On Undiagnosed And Uncontrolled Chronic Conditions

artículo científico publicado en 2015

Estimating equations to correct self-reported height and weight: implications for prevalence of overweight and obesity in Australia

artículo científico publicado en 2008

Estimating the association between SF-12 responses and EQ-5D utility values by response mapping

artículo científico publicado en 2006

Estimating the cost of complications of diabetes in Australia using administrative health-care data

artículo científico publicado en 2008

Estimating the cost of diabetes mellitus-related events from inpatient admissions in Sweden using administrative hospitalization data

artículo científico publicado en 2009

Estimating utility values for health states of overweight and obese individuals using the SF-36.

artículo científico publicado en 2005

Estimating utility values for health states of type 2 diabetic patients using the EQ-5D (UKPDS 62).

artículo científico publicado en 2002

Evaluating the costs and benefits of using combination therapies

artículo científico publicado en 2014

Event rates, hospital utilization, and costs associated with major complications of diabetes: a multicountry comparative analysis

artículo científico publicado en 2010

Expenditures and Prices of Antihyperglycemic Medications in the United States: 2002-2013.

artículo científico publicado en 2016

Factors influencing the cost of hospital care for people with diabetes in Australia

artículo científico publicado en 2006

Forgetting to remember or remembering to forget: a study of the recall period length in health care survey questions

artículo científico publicado en 2014

Funding grant proposals for scientific research: retrospective analysis of scores by members of grant review panel ⬇️

artículo científico publicado el 27 de septiembre de 2011

General practitioner screening for melanoma: sensitivity, specificity, and effect of training ⬇️

artículo científico publicado el 1 de enero de 1998

Group Testing for SARS-CoV-2: Forward to the Past?

artículo científico publicado en 2020

Health State Utility Value in Chronic Obstructive Pulmonary Disease (COPD); The Challenge of Heterogeneity: A Systematic Review and Meta-Analysis.

artículo científico

Health poverty among people with type 2 diabetes mellitus (T2DM) in Malaysia

artículo científico publicado en 2024

Horizontal inequities in Australia's mixed public/private health care system

artículo científico publicado en 2007

How Should a Safe and Effective COVID-19 Vaccine be Allocated? Health Economists Need to be Ready to Take the Baton

scientific article published on 03 September 2020

How fair is Medicare? The income-related distribution of Medicare benefits with special focus on chronic care items

scientific article published on 01 December 2012

Life expectancy in individuals with type 2 diabetes: implications for annuities

artículo científico publicado en 2009

Long-term disability associated with war-related experience among Vietnam veterans: retrospective cohort study.

artículo científico publicado en 2015

Measuring achievement: changes in risk factors for cardiovascular disease in Australia

artículo científico publicado en 2008

Measuring the Progressivity of the Pharmaceutical Benefits Scheme

Missing... presumed at random: cost-analysis of incomplete data

artículo científico publicado en 2003

On the measurement of relative and absolute income-related health inequality.

artículo científico publicado en 2002

On the time spent preparing grant proposals: an observational study of Australian researchers ⬇️

artículo científico publicado el 28 de mayo de 2013

Optimal recall length in survey design.

artículo científico publicado en 2008

Optimal strategies for identifying kidney disease in diabetes: properties of screening tests, progression of renal dysfunction and impact of treatment - systematic review and modelling of progression and cost-effectiveness

artículo científico

Optimal strategies for monitoring lipid levels in patients at risk or with cardiovascular disease: a systematic review with statistical and cost-effectiveness modelling

artículo científico publicado en 2015

Patterns of cancer care costs in a country with detailed individual data

artículo científico publicado en 2015

Performance of the UKPDS Outcomes Model for Prediction of Myocardial Infarction and Stroke in the ADDITION-Europe Trial Cohort: Does the ADDITION Validation Add Up?

article

Pharmacy diabetes care program: Analysis of two screening methods for undiagnosed type 2 diabetes in Australian community pharmacy

article

Predicting Changes in Cardiovascular Risk Factors in Type 2 Diabetes in the Post-UKPDS Era: Longitudinal Analysis of the Swedish National Diabetes Register

artículo científico publicado en 2013

Predicting mortality in people with type 2 diabetes mellitus after major complications: a study using Swedish National Diabetes Register data.

artículo científico publicado en 2014

Recent trends in life expectancy for people with type 1 diabetes in Sweden.

artículo científico publicado en 2016

Registered Reports: Time to Radically Rethink Peer Review in Health Economics

scientific article published on 01 March 2020

Risk equations to predict life expectancy of people with Type 2 diabetes mellitus following major complications: a study from Western Australia

artículo científico publicado en 2011

Self-rated health scores predict mortality among people with type 2 diabetes differently across three different country groupings: findings from the ADVANCE and ADVANCE-ON trials

scientific article published on 22 January 2020

Self-reported health: reliability and consequences for health inequality measurement

article

Severe hypoglycemia and mortality after cardiovascular events for type 1 diabetic patients in Sweden

artículo científico publicado en 2014

Simulating lifetime outcomes associated with complications for people with type 1 diabetes.

artículo científico publicado en 2013

Simulation of quality-adjusted survival in chronic diseases: an application in type 2 diabetes

artículo científico publicado en 2011

Survival of the fittest: retrospective cohort study of the longevity of Olympic medallists in the modern era

artículo científico publicado en 2012

Survival of the fittest: retrospective cohort study of the longevity of Olympic medallists in the modern era.

artículo científico publicado en 2015

Temporal validation of the UKPDS outcomes model using 10-year posttrial monitoring data

artículo científico publicado en 2012

Testing the convergent validity of the contingent valuation and travel cost methods in valuing the benefits of health care

artículo científico publicado en 2002

The economic analyses of the UK prospective diabetes study.

artículo científico publicado en 2008

The effect of diabetes complications on health-related quality of life: the importance of longitudinal data to address patient heterogeneity ⬇️

artículo científico publicado el 11 de julio de 2013

The effect of pentoxifylline on oxidative stress in chronic kidney disease patients with erythropoiesis-stimulating agent hyporesponsiveness: Sub-study of the HERO trial

artículo científico publicado en 2016

The effects of patient characteristics and geographical region on hospitalization in patients with Type 2 diabetes ⬇️

artículo científico publicado el 12 de abril de 2013

The effects of reduced copayments on discontinuation and adherence failure to statin medication in Australia.

artículo científico publicado en 2015

The impact of a streamlined funding application process on application time: two cross-sectional surveys of Australian researchers

artículo científico publicado en 2015

The impact of diabetes-related complications on healthcare costs: results from the United Kingdom Prospective Diabetes Study (UKPDS Study No. 65).

artículo científico publicado en 2003

The impact of funding deadlines on personal workloads, stress and family relationships: a qualitative study of Australian researchers

artículo científico publicado en 2014

The pricing of statins and implications for Pharmaceutical Benefits Scheme expenditure ⬇️

artículo científico publicado el 18 de marzo de 2013

Transparency in Decision Modelling: What, Why, Who and How?

scientific article published on 01 November 2019

Using Classification and Regression Trees (CART) to Identify Prescribing Thresholds for Cardiovascular Disease.

artículo científico publicado en 2015

Using Patient-Reported Outcomes for Economic Evaluation: Getting the Timing Right.

artículo científico publicado en 2016

Using simplified peer review processes to fund research: a prospective study

artículo científico publicado en 2015

Using the EQ-5D index score as a predictor of outcomes in patients with type 2 diabetes

artículo científico publicado en 2009

Which health-related quality of life score? A comparison of alternative utility measures in patients with Type 2 diabetes in the ADVANCE trial

artículo científico publicado en 2007

“Mirror, mirror, on the wall, who in this land is fairest of all?”—Distributional sensitivity in the measurement of socioeconomic inequality of health ⬇️

artículo científico publicado el 22 de noviembre de 2011

Lista de obras de Philip Clarke

A Patient-Level Model to Estimate Lifetime Health Outcomes of Patients With Type 1 Diabetes

A meta-analysis of health state valuations for people with diabetes: explaining the variation across methods and implications for economic evaluation ⬇️

A meta-analysis of the relative risk of mortality for type 1 diabetes patients compared to the general population: exploring temporal changes in relative mortality.

A model to estimate the lifetime health outcomes of patients with type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS) Outcomes Model (UKPDS no. 68).

A note on the decomposition of the health concentration index.

A randomized trial of fellowships for early career researchers finds a high reliability in funding decisions

A randomized, placebo-controlled trial of pentoxifylline on erythropoiesis-stimulating agent hyporesponsiveness in anemic patients with CKD: the Handling Erythropoietin Resistance With Oxpentifylline (HERO) trial

A randomized-controlled trial of high- or low-volume intravenous Plasma-Lyte(®) to prevent hypotension during sedation for colonoscopy

Adapting and validating diabetes simulation models across settings: Accounting for mortality differences using administrative data ⬇️

Alexander Sutherland: A Forgotten Pioneer of Health Economics in Australia?

Allogeneic blood transfusion reduces murine pulmonary natural killer (NK) activity and enhances lung metastasis of a syngeneic tumour

An economic evaluation of atenolol vs. captopril in patients with Type 2 diabetes (UKPDS 54).

Aspects of Multicomponent Integrated Care Promote Sustained Improvement in Surrogate Clinical Outcomes: A Systematic Review and Meta-analysis

Assessing the impact of visual acuity on quality of life in individuals with type 2 diabetes using the short form-36.

Calculating the concentration index when income is grouped

Can Self-Rated Health Scores Be Used for Risk Prediction in Patients With Type 2 Diabetes?

Challenges and opportunities for the Pharmaceutical Benefits Scheme

Change in bias in self-reported body mass index in Australia between 1995 and 2008 and the evaluation of correction equations

Changes in Inequalities of Access to Dental Care in Australia 1977-2005

Changes in Quality of Life Associated with Complications of Diabetes: Results from the ADVANCE Study

Citizens from 13 countries share similar preferences for COVID-19 vaccine allocation priorities

Comparability of patient-reported health status: multicountry analysis of EQ-5D responses in patients with type 2 diabetes

Cost effectiveness of self monitoring of blood glucose in patients with non-insulin treated type 2 diabetes: economic evaluation of data from the DiGEM trial.

Cost of Antihyperglycemic Medications in the United States—Reply

Cost-benefit analysis and mammographic screening: a travel cost approach

Cost-effectiveness analysis of intensive blood-glucose control with metformin in overweight patients with type II diabetes (UKPDS No. 51).

Cost-effectiveness of artemisinin combination therapy for uncomplicated malaria in children: data from Papua New Guinea

Cost-effectiveness of screening for anal cancer using regular digital ano-rectal examinations in men who have sex with men living with HIV

Cost-utility analyses of intensive blood glucose and tight blood pressure control in type 2 diabetes (UKPDS 72).

Cutting random funding decisions ⬇️

Development of life-expectancy tables for people with type 2 diabetes

Do Model-Based Studies in Chronic Obstructive Pulmonary Disease Measure Correct Values of Utility? A Meta-Analysis.

Does income-related health inequality change as the population ages? Evidence from Swedish panel data

End-stage renal disease risk equations for Hong Kong Chinese patients with type 2 diabetes: Hong Kong Diabetes Registry

Estimating Health-State Utility for Economic Models in Clinical Studies: An ISPOR Good Research Practices Task Force Report.

Estimating The Potential Impact Of Insurance Expansion On Undiagnosed And Uncontrolled Chronic Conditions

Estimating equations to correct self-reported height and weight: implications for prevalence of overweight and obesity in Australia

Estimating the association between SF-12 responses and EQ-5D utility values by response mapping

Estimating the cost of complications of diabetes in Australia using administrative health-care data

Estimating the cost of diabetes mellitus-related events from inpatient admissions in Sweden using administrative hospitalization data

Estimating utility values for health states of overweight and obese individuals using the SF-36.

Estimating utility values for health states of type 2 diabetic patients using the EQ-5D (UKPDS 62).

Evaluating the costs and benefits of using combination therapies

Event rates, hospital utilization, and costs associated with major complications of diabetes: a multicountry comparative analysis

Expenditures and Prices of Antihyperglycemic Medications in the United States: 2002-2013.

Factors influencing the cost of hospital care for people with diabetes in Australia

Forgetting to remember or remembering to forget: a study of the recall period length in health care survey questions

Funding grant proposals for scientific research: retrospective analysis of scores by members of grant review panel ⬇️

General practitioner screening for melanoma: sensitivity, specificity, and effect of training ⬇️

Group Testing for SARS-CoV-2: Forward to the Past?

Health State Utility Value in Chronic Obstructive Pulmonary Disease (COPD); The Challenge of Heterogeneity: A Systematic Review and Meta-Analysis.

Health poverty among people with type 2 diabetes mellitus (T2DM) in Malaysia

Horizontal inequities in Australia's mixed public/private health care system

How Should a Safe and Effective COVID-19 Vaccine be Allocated? Health Economists Need to be Ready to Take the Baton

How fair is Medicare? The income-related distribution of Medicare benefits with special focus on chronic care items

Life expectancy in individuals with type 2 diabetes: implications for annuities

Long-term disability associated with war-related experience among Vietnam veterans: retrospective cohort study.

Measuring achievement: changes in risk factors for cardiovascular disease in Australia

Measuring the Progressivity of the Pharmaceutical Benefits Scheme

Missing... presumed at random: cost-analysis of incomplete data

On the measurement of relative and absolute income-related health inequality.

On the time spent preparing grant proposals: an observational study of Australian researchers ⬇️

Optimal recall length in survey design.

Optimal strategies for identifying kidney disease in diabetes: properties of screening tests, progression of renal dysfunction and impact of treatment - systematic review and modelling of progression and cost-effectiveness

Optimal strategies for monitoring lipid levels in patients at risk or with cardiovascular disease: a systematic review with statistical and cost-effectiveness modelling

Patterns of cancer care costs in a country with detailed individual data

Performance of the UKPDS Outcomes Model for Prediction of Myocardial Infarction and Stroke in the ADDITION-Europe Trial Cohort: Does the ADDITION Validation Add Up?

Pharmacy diabetes care program: Analysis of two screening methods for undiagnosed type 2 diabetes in Australian community pharmacy

Predicting Changes in Cardiovascular Risk Factors in Type 2 Diabetes in the Post-UKPDS Era: Longitudinal Analysis of the Swedish National Diabetes Register

Predicting mortality in people with type 2 diabetes mellitus after major complications: a study using Swedish National Diabetes Register data.

Recent trends in life expectancy for people with type 1 diabetes in Sweden.

Registered Reports: Time to Radically Rethink Peer Review in Health Economics

Risk equations to predict life expectancy of people with Type 2 diabetes mellitus following major complications: a study from Western Australia

Self-rated health scores predict mortality among people with type 2 diabetes differently across three different country groupings: findings from the ADVANCE and ADVANCE-ON trials

Self-reported health: reliability and consequences for health inequality measurement

Severe hypoglycemia and mortality after cardiovascular events for type 1 diabetic patients in Sweden

Simulating lifetime outcomes associated with complications for people with type 1 diabetes.

Simulation of quality-adjusted survival in chronic diseases: an application in type 2 diabetes

Survival of the fittest: retrospective cohort study of the longevity of Olympic medallists in the modern era